{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T01:43:29Z","timestamp":1791855809235,"version":"4.3.4"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T00:00:00Z","timestamp":1688947200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T00:00:00Z","timestamp":1688947200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"The project of Clinical Advanced Techniques, Primary Research & Development Plan of Jiangsu Province","award":["BE2017719"],"award-info":[{"award-number":["BE2017719"]}]},{"name":"The Pediatric Medical Innovation Team of Jiangsu Province","award":["CXTDA2017022"],"award-info":[{"award-number":["CXTDA2017022"]}]},{"name":"The Major Specialty Project of Nanjing","award":["SZDZK2016009"],"award-info":[{"award-number":["SZDZK2016009"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"DOI":"10.1007\/s40620-023-01679-9","type":"journal-article","created":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T02:01:56Z","timestamp":1688954516000},"page":"1615-1625","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A clinicopathological and prognostic study of 18 children with C1q nephropathy and focal segmental glomerulosclerosis: an 18-year experience from a single center"],"prefix":"10.1093","volume":"36","author":[{"given":"Yingchao","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3281-8766","authenticated-orcid":false,"given":"Zhengkun","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiqiu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huangyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,7,10]]},"reference":[{"key":"1679_CR1","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0272-6386(85)80150-5","volume":"6","author":"JC Jennette","year":"1985","unstructured":"Jennette JC, Hipp CG (1985) C1q nephropathy: a distinct pathologic entity usually causing nephrotic syndrome. Am J Kidney Dis 6:103\u2013110","journal-title":"Am J Kidney Dis"},{"key":"1679_CR2","first-page":"2015","volume":"490413","author":"J Devasahayam","year":"2015","unstructured":"Devasahayam J, Erode-Singaravelu G, Bhat Z et al (2015) C1q nephropathy: the unique underrecognized pathological entity. Anal Cell Pathol (Amst) 490413:2015","journal-title":"Anal Cell Pathol (Amst)"},{"key":"1679_CR3","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s00467-013-2692-4","volume":"29","author":"VN Gunasekara","year":"2014","unstructured":"Gunasekara VN, Sebire NJ, Tullus K (2014) C1q nephropathy in children: clinical characteristics and outcome. Pediatr Nephrol 29:407\u2013413","journal-title":"Pediatr Nephrol"},{"key":"1679_CR4","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1681\/ASN.2007080929","volume":"19","author":"A Vizjak","year":"2008","unstructured":"Vizjak A, Ferluga D, Rozic M et al (2008) Pathology, clinical presentations, and outcomes of C1q nephropathy. J Am Soc Nephrol 19:2237\u20132244","journal-title":"J Am Soc Nephrol"},{"key":"1679_CR5","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1007\/s00467-005-2040-4","volume":"20","author":"T Kersnik Levart","year":"2005","unstructured":"Kersnik Levart T, Kenda RB, AvgustinCavi\u0107 M et al (2005) C1Q nephropathy in children. Pediatr Nephrol 20:1756\u20131761","journal-title":"Pediatr Nephrol"},{"key":"1679_CR6","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s00467-013-2551-3","volume":"29","author":"M VintarSpreitzer","year":"2014","unstructured":"VintarSpreitzer M, Vizjak A, Ferluga D et al (2014) Do C1q or IgM nephropathies predict disease severity in children with minimal change nephrotic syndrome? Pediatr Nephrol 29:67\u201374","journal-title":"Pediatr Nephrol"},{"key":"1679_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0215217","volume":"14","author":"K Kim","year":"2019","unstructured":"Kim K, Son HE, Ryu JY et al (2019) C1q nephropathy in adults is a form of focal segmental glomerulosclerosis in terms of clinical characteristics. PLoS ONE 14:e0215217","journal-title":"PLoS ONE"},{"key":"1679_CR8","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/S0031-3955(16)36251-4","volume":"34","author":"GJ Schwartz","year":"1987","unstructured":"Schwartz GJ, Brion LP, Spitzer A (1987) The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin N Am 34:571\u2013590","journal-title":"Pediatr Clin N Am"},{"key":"1679_CR9","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s12882-017-0637-z","volume":"18","author":"XH Chi","year":"2017","unstructured":"Chi XH, Li GP, Wang QS et al (2017) CKD-EPI creatinine-cystatin C glomerular filtration rate estimation equation seems more suitable for Chinese patients with chronic kidney disease than other equations. BMC Nephrol 18:226","journal-title":"BMC Nephrol"},{"key":"1679_CR10","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s11906-017-0780-8","volume":"19","author":"JM Dionne","year":"2017","unstructured":"Dionne JM (2017) Updated guideline may improve the recognition and diagnosis of hypertension in children and adolescents; review of the 2017 AAP blood pressure clinical practice guideline. Curr Hypertens Rep 19:84","journal-title":"Curr Hypertens Rep"},{"key":"1679_CR11","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1007\/s00467-020-04519-1","volume":"35","author":"A Trautmann","year":"2020","unstructured":"Trautmann A, Vivarelli M, Samuel S et al (2020) IPNA clinical practice recommendations for the diagnosis and management of children with steroid-resistant nephrotic syndrome. Pediatr Nephrol 35:1529\u20131561","journal-title":"Pediatr Nephrol"},{"key":"1679_CR12","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1053\/j.ajkd.2003.10.024","volume":"43","author":"VD D'Agati","year":"2004","unstructured":"D\u2019Agati VD, Fogo AB, Bruijn JA et al (2004) Pathologic classification of focal segmental glomerulosclerosis: a working proposal. Am J Kidney Dis 43:368\u2013382","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"1679_CR13","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.28701","volume":"5","author":"DS Gipson","year":"2022","unstructured":"Gipson DS, Troost JP, Spino C et al (2022) Comparing kidney health outcomes in children, adolescents, and adults with focal segmental glomerulosclerosis. JAMA Netw Open 5(8):e2228701","journal-title":"JAMA Netw Open"},{"key":"1679_CR14","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1046\/j.1523-1755.2003.00218.x","volume":"64","author":"GS Markowitz","year":"2003","unstructured":"Markowitz GS, Schwimmer JA, Stokes MB et al (2003) C1q nephropathy: a variant of focal segmental glomerulosclerosis. Kidney Int 64:1232\u20131240","journal-title":"Kidney Int"},{"issue":"4","key":"1679_CR15","first-page":"279","volume":"9","author":"GA Mokhtar","year":"2015","unstructured":"Mokhtar GA, Jalalah SM (2015) A clinicopathological study of C1q nephropathy at King Abdulaziz University. Iran J Kidney Dis 9(4):279\u2013285","journal-title":"Iran J Kidney Dis"},{"issue":"11","key":"1679_CR16","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1681\/ASN.2007080929","volume":"19","author":"A Vizjak","year":"2008","unstructured":"Vizjak A, Ferluga D, Rozic M et al (2008) Pathology, clinical presentations, and outcomes of C1q nephropathy. J Am Soc Nephrol 19(11):2237\u20132244. https:\/\/doi.org\/10.1681\/ASN.2007080929","journal-title":"J Am Soc Nephrol"},{"key":"1679_CR17","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s00467-008-1058-9","volume":"24","author":"CS Wong","year":"2009","unstructured":"Wong CS, Fink CA, Baechle J et al (2009) C1q nephropathy and minimal change nephrotic syndrome. Pediatr Nephrol 24:761\u2013767","journal-title":"Pediatr Nephrol"},{"key":"1679_CR18","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1007\/s00467-004-1810-8","volume":"20","author":"KK Lau","year":"2005","unstructured":"Lau KK, Gaber LW, Delos Santos NM et al (2005) C1q nephropathy: features at presentation and outcome. Pediatr Nephrol 20:744\u2013749","journal-title":"Pediatr Nephrol"},{"key":"1679_CR19","first-page":"54","volume":"4","author":"T Tibor F\u00fcl\u00f6p","year":"2015","unstructured":"Tibor F\u00fcl\u00f6p T, Csongr\u00e1di \u00c9, Lerant AA et al (2015) Resolution of C1q deposition but not of the clinical nephrotic syndrome after immunomodulating therapy in focal sclerosis. J Nephropathol 4:54\u201358","journal-title":"J Nephropathol"},{"key":"1679_CR20","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1681\/ASN.2012020187","volume":"24","author":"D Strassheim","year":"2013","unstructured":"Strassheim D, Renner B, Panzer S et al (2013) IgM contributes to glomerular injury in FSGS. J Am Soc Nephrol 24:393\u2013406","journal-title":"J Am Soc Nephrol"},{"key":"1679_CR21","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/ki.2015.120","volume":"88","author":"SE Panzer","year":"2015","unstructured":"Panzer SE, Laskowski J, Renner B et al (2015) IgM exacerbates glomerular disease progression in complement-induced glomerulopathy. Kidney Int 88:528\u2013537","journal-title":"Kidney Int"},{"key":"1679_CR22","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.2215\/CJN.01190216","volume":"11","author":"YM Zhang","year":"2016","unstructured":"Zhang YM, Gu QH, Huang J et al (2016) Clinical significance of IgM and C3 glomerular deposition in primary focal segmental glomerulosclerosis. Clin J Am Soc Nephrol 11:1582\u20131589","journal-title":"Clin J Am Soc Nephrol"},{"key":"1679_CR23","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1159\/000501827","volume":"44","author":"S Mirioglu","year":"2019","unstructured":"Mirioglu S, Caliskan Y, Ozluk Y et al (2019) Co-deposition of IgM and C3 may indicate unfavorable renal outcomes in adult patients with primary focal segmental glomerulosclerosis. Kidney Blood Press Res 44:961\u2013972","journal-title":"Kidney Blood Press Res"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-023-01679-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40620-023-01679-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-023-01679-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:52:48Z","timestamp":1777564368000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/36\/6\/1615\/8304242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,10]]},"references-count":23,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["1679"],"URL":"https:\/\/doi.org\/10.1007\/s40620-023-01679-9","relation":{},"ISSN":["1724-6059"],"issn-type":[{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,10]]},"assertion":[{"value":"23 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The clinical Trials Ethics Committee of the Jinling hospital reviewed and approved this study involving human participants (No. 2022DZKY-047-01). The data are anonymous, and the requirement for informed consent was therefore waived.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and Informed consent"}}]}}